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Abstract
Bacteria, fungi, protozoa, chromista and plants all harbor homologues of Hsp104, a AAA+ ATPase that collaborates with
Hsp70 and Hsp40 to promote protein disaggregation and reactivation. Curiously, however, metazoa do not possess an
Hsp104 homologue. Thus, whether animal cells renature large protein aggregates has long remained unclear. Here, it is
established that mammalian cytosol prepared from different sources possesses a potent, ATP-dependent protein
disaggregase and reactivation activity, which can be accelerated and stimulated by Hsp104. This activity did not require the
AAA+ ATPase, p97. Rather, mammalian Hsp110 (Apg-2), Hsp70 (Hsc70 or Hsp70) and Hsp40 (Hdj1) were necessary and
sufficient to slowly dissolve large disordered aggregates and recover natively folded protein. This slow disaggregase activity
was conserved to yeast Hsp110 (Sse1), Hsp70 (Ssa1) and Hsp40 (Sis1 or Ydj1). Hsp110 must engage substrate, engage
Hsp70, promote nucleotide exchange on Hsp70, and hydrolyze ATP to promote disaggregation of disordered aggregates.
Similarly, Hsp70 must engage substrate and Hsp110, and hydrolyze ATP for protein disaggregation. Hsp40 must harbor a
functional J domain to promote protein disaggregation, but the J domain alone is insufficient. Optimal disaggregase activity
is achieved when the Hsp40 can stimulate the ATPase activity of Hsp110 and Hsp70. Finally, Hsp110, Hsp70 and Hsp40 fail
to rapidly remodel amyloid forms of the yeast prion protein, Sup35, or the Parkinson’s disease protein, alpha-synuclein.
However, Hsp110, Hsp70 and Hsp40 enhanced the activity of Hsp104 against these amyloid substrates. Taken together,
these findings suggest that Hsp110 fulfils a subset of Hsp104 activities in mammals. Moreover, they suggest that Hsp104
can collaborate with the mammalian disaggregase machinery to rapidly remodel amyloid conformers.
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Introduction
The successful functioning of all cells depends on proper protein
folding [1]. Thus, cells maintain sophisticated protein homeostasis
(proteostasis) networks to ensure that protein biogenesis is
successful and that polypeptides effectively acquire, maintain and
(if necessary) reacquire their functional native structure [2].
Molecular chaperones engage polypeptide chains to assist protein
folding and prevent aggregation [3], degradation systems recog-
nize and eliminate terminally misfolded proteins [4], and protein
disaggregases reverse protein aggregation [5,6]. Despite these
safeguards, environmental stress, genetic background and aging
can all synergize to overwhelm the proteostasis network and the
consequences can be dire [7]. Indeed, protein misfolding and
aggregation are intimately connected with a series of increasing
prevalent and invariably fatal neurodegenerative disorders includ-
ing Alzheimer’s disease (AD), Parkinson’s disease (PD) and
Huntington’s disease (HD) [1,2,3,7,8].
The paucity of treatment options for these disorders reflects, at
least in part, a fundamental lack of basic understanding of the
mechanisms that cells use to safely reverse protein aggregation.
Indeed, protein disaggregases are perhaps the mostly poorly
understood components of proteostasis networks. Bacteria and the
vast majority of eukaryotes, including fungi, protozoa, chromista
and plants [9], possess homologues of the AAA+ ATPase, Hsp104.
Hsp104 collaborates with Hsp70 and Hsp40 to promote protein
disaggregation and reactivation [5,6,10,11]. This activity enables
these organisms to respond rapidly to protein-misfolding stress
(e.g. heat or chemical shock) by rescuing enzymatically active
proteins from denatured, amorphous protein aggregates
[12,13,14,15,16]. Thus, protein functionality is recovered rapidly
without incurring the large energetic and temporal costs expended
by degrading the protein and replacing it via transcription and
translation.
Hsp104 from yeast can even remodel extremely stable, amyloid
fibers [17,18,19,20,21], which adopt a highly ordered cross-beta
conformation [1,22]. This activity has enabled yeast to exploit
prions (infectious amyloids) for advantageous purposes [23,24,25].
The amyloid-remodeling activity of Hsp104 does not appear to be
strictly conserved, as the E. coli homologue ClpB does not appear
to be able to remodel amyloid [18,26,27]. Curiously, however,
Hsp104 does not have any metazoan homologues. Thus, whether
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26319or how animal cells might disaggregate and reactivate proteins has
long remained unclear.
The loss of Hsp104 from metazoan lineages is abrupt. The
choanoflagellate protist, Monosiga brevicollis, one of the most
advanced pre-metazoans has a clear Hsp104 homologue [28],
whereas even early branching metazoans like the sea anemone,
Nematostella vectensis do not [29]. The reason underlying the loss of
Hsp104 is unclear, especially because Hsp104 is well tolerated in
animal systems. For example, transgenic mice expressing Hsp104
appear normal [30,31] and Hsp104 increases stress tolerance of
animal cells in culture [31,32]. Moreover, Hsp104 rescues animal
models of PD [17] and HD [30,33,34].
Whether animals even possess an analogous protein disaggre-
gase, which functions to restore protein functionality remains
unclear [6,35]. Initial attempts to uncover such activities in
mammalian cells have been unsuccessful [32]. More recently,
crude C. elegans and mammalian extracts have been shown to
possess a slow amyloid disaggregation activity that is tightly linked
to protein degradation [36,37,38]. The identity of the disaggre-
gase, however, which exhibits unusual properties such as resistance
to high temperature (e.g. 80uC), remains unclear [36,37,38].
The search for functional equivalents of Hsp104 has led
researchers to consider other members of the diverse AAA+
protein family. It has been suggested that one highly conserved
candidate, p97 (also known as VCP or Cdc48), might perform a
disaggregase function [39]. Indeed, p97 can act as a molecular
chaperone and prevent protein aggregation [40,41], and even
appears to regulate some amyloid misfolding events in a manner
similar to Hsp104 [42]. Moreover, p97 can collaborate with
Hsp70 and Hsp40 to refold soluble misfolded conformers [43].
However, no convincing demonstration of p97-catalyzed disag-
gregation has been forthcoming using pure components.
It has also been suggested that in the absence of Hsp104, high
concentrations of metazoan Hsp70 and Hsp40 might suffice to
promote protein disaggregation [44,45,46]. However, Hsp70 and
Hsp40 are unable to rapidly remodel amyloid [17,20,47] and fail
to disaggregate large amorphous protein aggregates [10,32,44,46].
Thus, it continues to remain unclear whether protein disaggrega-
tion and reactivation are ever coupled in metazoa, or whether
metazoan proteostasis is more centered on clearing aggregated
proteins via autophagy and other proteolytic systems [4].
Here, a potent metazoan disaggregase and renaturation
machinery is uncovered using a cell-free system. It is established
that mammalian cytosol can disaggregate and reactivate aggre-
gated proteins in an ATP-dependent manner. Hsp70 and Hsp40
chaperones play key roles in this process. However, using pure
components it is demonstrated that Hsp70 and Hsp40 are not
sufficient. Indeed, it is established that an Hsp70-related
chaperone with Hsp70 nucleotide exchange activity, Hsp110
[48,49,50,51,52,53,54,55,56], is also needed. Hsp110 synergizes
with Hsp70 and Hsp40 to drive protein disaggregation and
reactivation in mammalian cytosol and in a minimal pure protein
setting.
Results and Discussion
Mammalian cytosol possesses ATP-dependent
disaggregase activity that is enhanced by Hsp104
First, it was tested whether cytosol preparations from two
mammalian sources, rat liver and sHeLa cells, possessed any
intrinsic protein disaggregation and reactivation activity. Two classic
model aggregated substrates that are widely employed for protein
disaggregation experiments with Hsp104 and ClpB were used: urea-
denatured luciferase, which forms aggregated structures of ,500–
2,000 kDa and greater in size [10], and heat-denatured GFP, which
forms a continuum of aggregated structures of ,500 kDa and
greater in size [57,58,59]. For comparison, purified Hsp104, Ssa1
and Sis1 from yeast were employed, which rapidly disaggregated
bothluciferase(Figure1A,C) and GFP (Figure1B,D) within 30 min
to 1 h. By contrast, neither rat liver cytosol (RLC) nor sHeLa cytosol
(SHC) could disaggregate and reactivate significant amounts of
luciferase (Figure 1A, C) or GFP (Figure 1B, D) in this time frame.
AdditionofHsp104toRLCorSHCstimulatedrapiddisaggregation
and reactivation ofluciferase(Figure 1A,C) and GFP (Figure 1B,D),
indicating that Hsp104 is fully competent to collaborate with the
mammalian proteostasis machinery.
Importantly, RLC and SHC were not completely inactive. After
longer incubations of 4 h or more, both RLC and SHC
reactivated luciferase (Figure 1A, C) and GFP (Figure 1B, D).
RLC (Figure 1A, B) possessed slightly greater activity than SHC
(Figure 1C, D). This activity depended upon ATP hydrolysis, and
was not observed when cytosol was not supplemented with ATP or
if AMP-PNP (a non-hydrolyzable ATP analogue) was supple-
mented in place of ATP, or if ATP was depleted by apyrase
treatment (Figure 1A-D). Thus, the mammalian cytosol harbors an
ATPase-dependent protein disaggregation activity.
p97 is not required for the disaggregase activity
A candidate-based approach was employed to identify the ATP-
dependent disaggregases. First, the AAA+ ATPase, p97, was
considered. p97 was depleted by greater than 98% from RLC and
SHC, using a p97-binding fragment of Ufd1, UT6, fused to GST
(Figure 2A, B) [60]. Both p97-depleted RLC and p97-depleted
SHC could disaggregate and reactivate luciferase (Figure 2C, D)
and GFP (Figure 2E, F). A small molecule, DBeQ, which potently
and selectively inhibits the ATPase activity of p97 [61], had no
effect on protein disaggregation by either RLC (Figure 2C, E) or
SHC (Figure 2D, F). Thus, p97 is unlikely to contribute to the
observed disaggregase activity.
The Hsp70 chaperone system is a key component of the
disaggregase machinery
Next, the Hsp70 chaperone system was considered. First, Hsp70
(a heat-inducible Hsp70 that is not expressed at high levels under
non-stressful conditions) was immunodepleted by greater than
98% (Figure 2A, B). Hsp70 immunodepletion had only a slight
effect on the disaggregase activity of RLC and SHC (Figure 2C–
F). By contrast, immunodepletion of Hsc70 (the constitutive Hsp70
chaperone) by greater than 95% (Figure 2A, B), severely reduced
the disaggregase activity of RLC and SHC (Figure 2C–F).
Importantly, adding pure Hsc70 back to Hsc70-depleted cytosol
restored full disaggregase activity (Figure 2C–F). Thus, Hsc70 itself
drives the disaggregase activity, and not other factors that may
have been co-depleted during immunodepletion of Hsc70.
Moreover, a small molecule inhibitor of Hsp70 and Hsc70
ATPase activity, VER 155008 [62], inhibited the disaggregation of
activity of RLC and SHC (Figure 2C–F). These data suggest that
the Hsp70 chaperone system is a critical component of the
mammalian disaggregation machinery.
Next, the role of Hsp40 co-chaperones was assessed. Hdj1 or
Hdj2 were immunodepleted from RLC (Figure 2A) and SHC
(Figure 2B) by ,100%. Depletion of Hdj2 had no effect on
disaggregase activity (Figure 2C–F), whereas depletion of Hdj1
eliminated activity (Figure 2C–F). Importantly, adding pure Hdj1
back to Hdj1-depleted cytosol restored full disaggregase activity,
reinforcing the importance of Hdj1 itself (Figure 2C–F). These
data suggest that Hsc70 and Hdj1 are key components of the
mammalian disaggregase machinery.
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robust protein disaggregation
The previous experiments defined Hsc70 and Hdj1 as key
components of the disaggregase machinery present in mammalian
cytosol. Could this machinery be reconstituted using pure proteins?
Thus, the ability of Hsc70:Hdj1, Hsc70:Hdj2, Hsp70:Hdj1 and
Hsp70:Hdj2 pairs to disaggregate luciferase and GFP was tested.
Consistent,with the immunodepletion studies(Figure 2),Hsc70:Hdj2
and Hsp70:Hdj2 did not disaggregate luciferase (Figure 3A) or GFP
(Figure 3B). By contrast, Hsc70:Hdj1 and Hsp70:Hdj1 displayed
some disaggregase activity (Figure 3A, B). However, the recovery of
folded luciferase and GFP by Hsc70:Hdj1 or Hsp70:Hdj1 was ,10-
fold less than that achieved by RLC or SHC (Figure 3A, B), or by
Hsp104, Ssa1 and Sis1 (Figure 3A, B). Mixing Hsc70:Hdj1 and
Hsp70:Hdj1 did not increase activity any further (Figure 3A, B).
Moreover, increasing the Hsc70:Hdj1 and Hsp70:Hdj1 concentra-
tion 20-fold also failed to increase disaggregase activity. These data
suggested that additional factors were needed to reconstitute the full
disaggregase activity of RLC and SHC.
Hsp104 synergizes with mammalian Hsp70:Hsp40 pairs
to promote protein disaggregation
Interestingly, Hsc70:Hdj1 and Hsp70:Hdj1 were more active in
protein disaggregation than the yeast Hsp70:Hsp40 pairs:
Ssa1:Ydj1 and Ssa1:Sis1 (Figure 3A, B). These data indicate that
the mammalian Hsp70 chaperone system might have evolved
Figure 1. Mammalian cytosol contains an ATPase-dependent disaggregation machinery. (A, B) Urea-denatured luciferase aggregates
(50 nM) (A, C) or heat-denatured GFP aggregates (0.45 mM) (B, D) were incubated for 30 min (blue bars), 1 h (green bars), 4 h (black bars), or 6 h (red
bars) at 25uC in buffer plus ATP (5 mM) and ATP-regeneration system without or with the indicated combination of Hsp104 (1 mM), Ssa1 (1 mM), Sis1
(1 mM), RLC (10 mg/ml) (A, B), or SHC (10 mg/ml) (C, D). In the indicated reactions, ATP was omitted or replaced with AMP-PNP. Alternatively, ATP
was included but the ATP-regeneration system was replaced with apyrase. Disaggregation and reactivation of luciferase was monitored by
luminescence. Luminescence measurements were converted into reactivation yield (% of the maximum recoverable luciferase activity) by comparison
to the luminescence of known quantities of soluble, native luciferase (A, C). Disaggregation and reactivation of GFP was monitored by fluorescence.
Fluorescence measurements were converted into reactivation yield (% of the maximum recoverable GFP fluorescence) by comparison to the
fluorescence of known quantities of soluble, native GFP (B, D). Values represent means 6 SEM (n=3).
doi:10.1371/journal.pone.0026319.g001
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PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e26319Figure 2. Hsp110, Hsp70 and Hsp40 are key components of the mammalian disaggregation machinery. (A, B) Immunoblots showing
depletion of either p97, Hsp70, Hsc70, Hdj1, Hdj2, Hsp105 or Apg-2 from either RLC (A) or SHC (B) as described in Materials and Methods. 20 mgo f
cytosol was fractionated by SDS-PAGE and processed for immunoblot. (C–F) Urea-denatured luciferase aggregates (50 nM) (C, D) or heat-denatured
GFP aggregates (0.45 mM) (E, F) were incubated for 6 h in buffer plus ATP (5 mM) and ATP-regeneration system without or with the indicated cytosol
(10 mg/ml), mock-depleted cytosol (10 mg/ml) or depleted cytosol (10 mg/ml). In the indicated reactions, the small molecule p97 inhibitor, DBeQ
(100 mM), or Hsp70 inhibitor, VER 155008 (100 mM), were included. In the indicated reactions, Hsc70-depleted cytosol was supplemented with Hsc70,
Hdj1-depleted cytosol was supplemented with Hdj1 and Apg-2-depleted cytosol was supplemented with Apg-2 as described in Materials and
Methods. Disaggregation and reactivation of luciferase was monitored by luminescence. Luminescence measurements were converted into
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homologue. Hsp104 could synergize with all the mammalian
Hsp70:Hsp40 pairs tested here: Hsc70:Hdj1, Hsc70:Hdj2,
Hsp70:Hdj1 and Hsp70:Hdj2 to promote rapid luciferase and
GFP disaggregation and reactivation (Figure 3A, B). These data
suggested that Hsp104 could collaborate with various mammalian
Hsp70 and Hsp40 chaperones. Moreover, the disaggregase
activity of Hsp104 with Hsc70:Hdj1 or Hsp70:Hdj1 was very
similar to that of Hsp104 with Ssa1:Sis1 (Figure 3A, B). Thus, in
contrast to the inability of Hsp104 to collaborate with prokaryotic
Hsp70 (DnaK) [10] there does not appear to be a ‘species barrier’
between Hsp104 and mammalian chaperones, which helps
explain why Hsp104 can confer therapeutic benefits for protein
misfolding disorders in several metazoan settings [17,30,32,33,34].
Hsp110 is an essential component of the cytosolic
disaggregase machinery
The ability of Hsp104 to synergize with Hsc70:Hdj1 and
Hsp70:Hdj1, and the low activity of these Hsp70:Hsp40 pairs
compared to RLC or SHC, suggested that other factors in
mammalian cytosol might contribute to protein disaggregation.
One obvious candidate was Hsp110, a divergent relative of
Hsp70 that can stabilize unfolded proteins [63,64,65] and serve
as a nucleotide exchange factor for Hsp70 [54,56]. Moreover,
Hsp110 may co-operate with Hsp70 to assist protein folding [53].
Thus, two Hsp110 variants: Hsp105, a heat-inducible Hsp110
[66], or Apg-2, a constitutive Hsp110 [67], were immunode-
pleted by greater than ,93% from RLC (Figure 2A) and SHC
(Figure 2B). Hsp105-depleted cytosol had slightly reduced
luciferase and GFP disaggregase activity, whereas Apg-2-
depleted cytosol had greatly reduced disaggregase activity
(Figure 2C–F). In fact, Apg-2 depletion reduced disaggregase
activity (Figure 2C–F) to levels provided by Hsc70:Hdj1 or
Hsp70:Hdj1 in isolation (Figure 3A, B). Addition of pure Apg-2
back to Apg-2-depleted RLC or SHC restored disaggregase
activity to that of untreated or mock-depleted cytosol (Figure 2C–
F), indicating that Apg-2 itself was a critical determinant
supporting protein disaggregation.
Pure Hsp110 synergizes the Hsp70 and Hsp40 to
promote protein disaggregation in a minimal system
Next, Apg-2 was added to pure protein disaggregation assays.
Apg-2 synergized with Hsc70:Hdj1 and Hsp70:Hdj1 to promote
disaggregation of luciferase (Figure 3A) and GFP (Figure 3B). The
addition of Apg-2 increased disaggregase activity to levels
approaching that of RLC and SHC (Figure 3A, B). Notably,
Apg-2 did not catalyze protein disaggregation alone or in
combination with Hsc70, Hsp70 or Hdj1 alone (Figure 3A, B).
Furthermore, Apg-2 did not synergize with Hsc70:Hdj2 or
Hsp70:Hdj2 (Figure 3A, B). Importantly, just like the disaggregase
activity of RLC and SHC, the disaggregase activity of Apg-
2:Hsc70:Hdj1 or Apg-2:Hsc70:Hdj1 was inhibited by the absence
of adenine nucleotide, by AMP-PNP, when ATP was depleted
with apyrase, and by the small molecule Hsp70 inhibitor VER
155008 (Figure 3A, B). Apg-2 did not stimulate disaggregase
activity as much or as rapidly as Hsp104 (Figure 3A, B). However,
the combination of Hsp104, Apg-2 with either Hsc70:Hdj1 or
Hsp70:Hdj1, yielded the most efficacious protein disaggregation
(Figure 3A, B). Together these data clearly establish that, even in
the absence of Hsp104, mammalian Hsp110 synergizes with
Hsp70 and Hsp40 to promote the disaggregation and reactivation
of large protein aggregates.
Hsp110 disaggregase activity is conserved to yeast Sse1
The ability of Hsp110 to synergize with Hsp70 and Hsp40 to
promote protein disaggregation and reactivation was conserved
to the yeast Hsp110 homologue, Sse1. Thus, Sse1 synergized with
Ssa1:Sis1 to promote disaggregation of luciferase (Figure 4A) and
GFP (Figure 4B). Here too, disaggregation proceeded with slower
kinetics than in the presence of Hsp104, Ssa1 and Sis1 and lower
amounts of folded luciferase and GFP could be recovered
(Figure 4A, B). Sse1 was inactive alone or when paired with Ssa1
alone or Sis1 alone (Figure 4A, B). Moreover, the activity of
Sse1:Ssa1:Sis1 was inhibited by the absence of adenine
nucleotide, by AMP-PNP, or when ATP was depleted with
apyrase (Figure 4A, B). Interestingly, addition of Sse1 to Hsp104,
Ssa1 and Sis1 yielded a more rapid and potent disaggregase
activity (Figure 4A, B).
Sse1 must bind Ssa1, substrate and hydrolyze ATP to
promote protein disaggregation
The ability of Sse1 to synergize with Ssa1:Sis1 to promote
protein disaggregation allowed an assessment of the importance of
Sse1 NEF activity, ATPase activity and substrate-binding activity
for disaggregation by employing well-defined Sse1 mutants [53].
First, it was tested whether the NEF activity of Sse1 was important
for protein disaggregation. A Sse1 mutant without NEF activity,
Sse1
N572Y,E575A [53], failed to promote luciferase and GFP
disaggregation by Ssa1:Sis1 (Figure 4C, D). Similarly, an Ssa1
mutant, Ssa1
A300E [53], which cannot engage Sse1, could not
promote protein disaggregation (Figure 4C, D). Thus, Sse1 and
Ssa1 must interact in a manner that enables Ssa1 nucleotide
exchange to promote protein disaggregation. However, NEF
activity alone was not sufficient. Two other Ssa1 NEFs: Fes1 [68]
and Snl1DN [69,70] could not substitute for Sse1 in the promotion
of protein disaggregation (Figure 4C, D).
These data suggested that Sse1 was not functioning as a simple
NEF to promote protein disaggregation. To assess other Sse1
functionalities, we employed Sse1
K69M, which has defective
ATPase activity [49]. Sse1
K69M, Ssa1 and Sis1 failed to promote
luciferase (Figure 4C) or GFP disaggregation (Figure 4D).
Sse1
K69M is fully functional as a Ssa1 NEF [56]. Thus, these data
indicate that Sse1 must do more than simply promote Ssa1
nucleotide exchange to promote disaggregation. An ATPase
defective Ssa1 variant, Ssa1
K69Q [71], also eliminated disaggregase
activity (Figure 4C, D). Thus, both Ssa1 and Sse1 must hydrolyze
ATP to promote protein disaggregation.
Next, Sse1 variants bearing mutations in the putative peptide-
binding site were assessed [53]. Sse1
L443A, N434P and Sse1
F439L,
M441A both failed to promote luciferase or GFP disaggregation by
Ssa1 and Sis1 (Figure 4C, D). Similarly, an Ssa1 variant defective
in substrate binding, Ssa1
L483W [72], eliminated disaggregase
activity (Figure 4C, D). Thus, both Sse1 and Ssa1 must engage
substrate to promote protein disaggregation.
reactivation yield (% of the maximum recoverable luciferase activity) by comparison to the luminescence of known quantities of soluble, native
luciferase (C, D). Disaggregation and reactivation of GFP was monitored by fluorescence. Fluorescence measurements were converted into
reactivation yield (% of the maximum recoverable GFP fluorescence) by comparison to the fluorescence of known quantities of soluble, native GFP (E,
F). Values represent means 6 SEM (n=3).
doi:10.1371/journal.pone.0026319.g002
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PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e26319Figure 3. Pure Hsp110, Hsp70 and Hsp40 drive protein disaggregation. (A, B) Urea-denatured luciferase aggregates (50 nM) (A) or heat-
denatured GFP aggregates (0.45 mM) (B) were incubated for 30 min (blue bars) or 6 h (red bars) at 37uC in buffer plus ATP (5 mM) and ATP-
regeneration system without or with the indicated combination of Hsp104 (1 mM), Ssa1 (1 mM), Ydj1 (1 mM), RLC (10 mg/ml), SHC (10 mg/ml), Hsc70
(1 mM), Hdj1 (1 mM), Hdj2 (1 mM), Hsp70 (1 mM) and Apg-2 (1 mM). In the indicated reactions, ATP was omitted or replaced with AMP-PNP.
Alternatively, ATP was included but the ATP-regeneration system was replaced with apyrase. The small molecule inhibitor VER 155008 (100 mM) was
included in the indicated reactions. Disaggregation and reactivation of luciferase was monitored by luminescence. Luminescence measurements
were converted into reactivation yield (% of the maximum recoverable luciferase activity) by comparison to the luminescence of known quantities of
soluble, native luciferase (A). Disaggregation and reactivation of GFP was monitored by fluorescence. Fluorescence measurements were converted
into reactivation yield (% of the maximum recoverable GFP fluorescence) by comparison to the fluorescence of known quantities of soluble, native
GFP (B). Values represent means 6 SEM (n=3).
doi:10.1371/journal.pone.0026319.g003
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PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e26319Figure 4. Hsp110 NEF activity, ATPase activity and substrate-binding activity are essential for protein disaggregation. (A, B) Urea-
denatured luciferase aggregates (50 nM) (A) or heat-denatured GFP aggregates (0.45 mM) (B) were incubated for 30 min (blue bars), 1 h (green bars),
4 h (black bars), or 6 h (red bars) at 25uC in buffer plus ATP (5 mM) and ATP-regeneration system without or with the indicated combination of
Hsp104 (1 mM), Ssa1 (1 mM), Sis1 (1 mM) and Sse1 (1 mM). In the indicated reactions, ATP was either omitted or replaced with AMP-PNP. Alternatively,
ATP was included but the ATP-regeneration system was replaced with apyrase. Disaggregation and reactivation of luciferase was monitored by
luminescence. Luminescence measurements were converted into reactivation yield (% of the maximum recoverable luciferase activity) by comparison
to the luminescence of known quantities of soluble, native luciferase (A). Disaggregation and reactivation of GFP was monitored by fluorescence.
Fluorescence measurements were converted into reactivation yield (% of the maximum recoverable GFP fluorescence) by comparison to the
fluorescence of known quantities of soluble, native GFP (B). Values represent means 6 SEM (n=3). (C, D) Urea-denatured luciferase aggregates
(50 nM) (C) or heat-denatured GFP aggregates (0.45 mM) (D) were incubated for 30 min (blue bars), 1 h (green bars), 4 h (black bars), or 6 h (red bars)
at 25uC in buffer plus ATP (5 mM) and ATP-regeneration system without or with the indicated combination of Ssa1 (1 mM), Sis1 (1 mM), Sse1 (1 mM),
Sse1
N572Y:E575A (1 mM, a NEF-defective Sse1 mutant), Ssa1
A300E (1 mM, an Ssa1 mutant unable to interact with Sse1), Fes1 (1 mM, a Ssa1 NEF), Snl1DN
(1 mM, a Ssa1 NEF), Sse1
K69M (1 mM, an ATPase-dead Sse1 mutant), Ssa1
K69Q (1 mM, an ATPase-dead Ssa1 mutant), Sse1
L433A:N434P (1 mM, a substrate-
binding defective Sse1 mutant), Sse1
F439L:M441A (1 mM, a substrate-binding defective Sse1 mutant), Ssa1
L483W (1 mM, a substrate-binding defective
Ssa1 mutant), Sis1
H34Q (1 mM, a Sis1 mutant unable to stimulate Ssa1 ATPase activity), Sis1
1–68 (1 mM, the J domain of Sis1), Sis1
1–121 (1 mM, the J and
G/F-domains of Sis1) and Ydj1 (1 mM, an Hsp40). Disaggregation and reactivation of luciferase was monitored by luminescence. Luminescence
measurements were converted into reactivation yield (% of the maximum recoverable luciferase activity) by comparison to the luminescence of
known quantities of soluble, native luciferase (C). Disaggregation and reactivation of GFP was monitored by fluorescence. Fluorescence
measurements were converted into reactivation yield (% of the maximum recoverable GFP fluorescence) by comparison to the fluorescence of
known quantities of soluble, native GFP (D). Values represent means 6 SEM (n=3).
doi:10.1371/journal.pone.0026319.g004
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Next, the role of Sis1 in the disaggregation reaction was probed.
Must Sis1 stimulate Hsp70 ATPase activity to promote disaggre-
gation? To answer this question, a J domain mutant, Sis1
H34Q,
which is unable to stimulate Hsp70 ATPase activity was employed
[73]. Sis1
H34Q failed to support protein disaggregation (Figure 4C,
D), indicating that the ability of Sis1 to stimulate Hsp70 ATPase
activity is important for protein disaggregation. However, a
functional J domain was not sufficient: Sis1 truncation mutants
bearing only the J domain, Sis1
1–68 [73], or the J domain plus the
G/F domain, Sis1
1–121 [73], could not support protein disaggre-
gation (Figure 4C, D). Thus, Sis1 must perform other functions
beyond stimulating Hsp70 ATPase activity to promote protein
disaggregation.
Sis1 can stimulate Ssa1 and Sse1 ATPase activity, whereas
another yeast Hsp40, Ydj1, stimulates Ssa1 ATPase activity but
not Sse1 ATPase activity [49]. To test the importance of the ability
of Sis1 to stimulate Sse1 ATPase activity for protein disaggrega-
tion, Sis1 was substituted with Ydj1. Sse1, Ssa1 and Ydj1
supported protein disaggregation, but not as effectively as Sse1,
Ssa1 and Sis1 (Figure 4C, D). Thus, one key role of the Hsp40
appears to be to stimulate Ssa1 ATPase activity, whereas the
stimulation of Sse1 ATPase activity appears to be less important.
Hsp110, Hsp70 and Hsp40 do not rapidly remodel
amyloid
Could Hsp110, Hsp70 and Hsp40 disaggregate amyloid
conformers? Sse1, Ssa1 and Sis1 were tested against infectious
amyloid forms of the yeast prion protein, Sup35 [19]. SDS-
resistance and Thioflavin-T (ThT) fluorescence were employed to
monitor Sup35 prion integrity [19,20,74]. Sse1, Ssa1 and Sis1
were ineffective in remodeling Sup35 prions (Figure 5A, B). Even a
tenfold excess of Sse1, Ssa1, and Sis1 over Sup35 had no effect
(Figure 5A, B). Moreover, increasing the reaction time to 24 h did
not yield any disassembly. By contrast, Hsp104 could remodel
Sup35 prions in the absence of Sse1, Ssa1 and Sis1 (Figure 5A, B)
[19,20]. Addition of binary combinations of Sse1, Ssa1 and Sis1
had little effect on Hsp104 activity (Figure 5A, B). By contrast,
addition of Sse1, Ssa1 and Sis1 yielded greater Sup35 prion
remodeling by Hsp104 (Figure 5A, B). These data are consistent
with in vivo observations that Sse1 promotes Sup35 prion
fragmentation by Hsp104 [75,76]. Thus, although ineffective
alone, Sse1, Ssa1 and Sis1 can enhance Sup35 prion remodeling
by Hsp104.
Next, it was tested whether Apg-2:Hsc70:Hdj1 or Apg-
2:Hsp70:Hdj1 could remodel amyloid conformers comprised of
the PD protein a-synuclein (a-syn). Here too, Apg-2:Hsc70:Hdj1
or Apg-2:Hsp70:Hdj1 were ineffective alone (Figure 5C, D). By
contrast, Hsp104 rapidly remodeled a-syn fibers in a manner that
was enhanced by the addition of Apg-2:Hsc70:Hdj1 or Apg-
2:Hsp70:Hdj1 (Figure 5C, D). Taken together these data suggest
that although capable of slowly resolving large denatured protein
aggregates, Hsp110, Hsp70 and Hsp40 fail to rapidly remodel
amyloid. Thus, it appears as though they only fulfill a subset of
Hsp104 disaggregase activities. However, Hsp104 can synergize
with mammalian Hsp110, Hsp70 and Hsp40 to promote the
disaggregation of amyloid conformers (Figure 5C, D) and
amorphous, disordered aggregates (Figure 3A, B).
Hsp110, Hsp70 and Hsp40: a mammalian disaggregase
system
Collectively, these findings suggest that Hsp110, Hsp70 and
Hsp40 constitute a disaggregase machinery active in the
mammalian cytosol, which is able to recover natively folded
proteins from large chemically or thermally denatured protein
aggregates. This activity appears to be specific for disordered,
amorphous aggregates. Hsp110, Hsp70 and Hsp40 were unable to
disaggregate amyloid conformers. Thus, the metazoan amyloid
disaggregation activity uncovered by Cohen, Dillin, Kelly and
colleagues, which is tightly coupled to protein degradation rather
than protein reactivation, is likely to be composed of different
components [36,37,38]. Indeed, it may be that metazoa rely
primarily on autophagy or other lysosomal processes to clear
amyloid conformers that accumulate in the cytoplasm [4].
Nonetheless, it is now clear that metazoa have disaggregase
systems in place that can couple protein disaggregation to protein
renaturation or protein degradation. Activating these pathways
might prove to be a useful therapeutic strategy against numerous
disorders connected with protein misfolding and aggregation
[1,2,8].
The disaggregase activity of Hsp110, Hsp70 and Hsp40 was
conserved to the yeast homologues. Thus, Sse1, Ssa1 and Sis1
could synergize to rescue proteins from large disordered
aggregates. This activity only allowed a slow rescue of active
protein, in contrast to Hsp104-catalyzed reactions. These slow
kinetics might explain why Sse1, Ssa1 and Sis1 cannot provide
thermotolerance to yeast that lack Hsp104. Rather, the rapid
protein disaggregation and reactivation catalyzed by Hsp104
appears critical for stress tolerance in vivo [12]. Notably, however,
Hsp104 was more effective when combined with Sse1, Ssa1 and
Sis1 than with Ssa1 and Sis1 alone. Thus, Sse1 assists Hsp104-
catalyzed disaggregation.
Using a series of well-defined Sse1 mutants [53], it was evident
that Sse1 must engage substrate, engage Hsp70, promote
nucleotide exchange on Hsp70, and hydrolyze ATP to promote
disaggregation of disordered aggregates. The requirement for all of
these Sse1 functionalities distinguishes Sse1’s function in protein
disaggregation from its role in preventing protein aggregation,
where the ATPase activity is dispensable [63]. Similarly, the role of
Sse1 in assisting Ssa1 and Ydj1 in refolding soluble misfolded
luciferase does not require Sse1 ATPase activity and the
requirement for Sse1-peptide interactions is less stringent [53].
Here, the Hsp70 NEF activity is paramount [53]. For protein
disaggregation, the Sse1 NEF activity is also essential, but it is not
sufficient as neither Fes1 nor Snl1DN (two Ssa1 NEFs) could
substitute for Sse1. Ssa1 must also hydrolyze ATP, engage
substrate and Sse1 to promote protein disaggregation. Further-
more, protein disaggregation was most effective when the Hsp40
stimulated both Ssa1 and Sse1 ATPase activity. However, a J
domain was not sufficient indicating that Hsp40 must perform
other functions beyond stimulating Hsp70 and Hsp110 ATPase
activity. Taken together, these data suggest that the synergy
between Sse1, Ssa1 and Sis1 in protein disaggregation might
reflect a coupling of Sse1 and Ssa1 ATPase activity to co-operative
substrate handling, which gradually dissociates proteins from the
aggregate surface. Thus, Hsp110 might potentiate ‘entropic
pulling’ by Hsp70 [45,77].
Although Hsp110, Hsp70 and Hsp40 were unable to remodel
amyloid conformers, they did permit more effective amyloid
remodeling by Hsp104. For example, Hsp104 more effectively
eradicated amyloid forms of a-syn in the presence of Apg-2,
Hsc70 and Hdj1 than in their absence. The ability of Hsp104 to
interface with the mammalian disaggregase machinery and
enable effective clearance of amyloid conformers might hold
promise for applying Hsp104 to various devastating protein-
misfolding disorders [6,35].
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PLoS ONE | www.plosone.org 8 October 2011 | Volume 6 | Issue 10 | e26319Figure 5. Pure Hsp110, Hsp70 and Hsp40 enhance Hsp104 disaggregase activity against Sup35 prions and a-syn amyloid fibers. (A,
B) Preformed Sup35 prions (2 mM monomer) were incubated for 6 h at 25uC in buffer plus ATP (5 mM) and ATP-regeneration system without or with
the indicated combination of Ssa1 (2 mM), Sis1 (2 mM), Sse1 (2 mM) (each individual combination is an individual category of the x-axis) in the absence
(blue bars) or presence of Hsp104 (0.5 mM, green bars; or 2 mM, black bars). For the 10x(Sse1+Ssa1+Sis1) condition the concentration of Ssa1, Sis1 and
Sse1 was increased to 20 mM. Sup35 prion disassembly was assessed by the amount of SDS-resistant Sup35 (A) or by ThT fluorescence (B). Values
represent means 6 SEM (n=3). (C, D) Preformed amyloid fibers composed of a-syn (0.5 mM monomer) were incubated for 6 h at 37uC in buffer plus
ATP (5 mM) and ATP-regeneration system without or with the indicated combination of Hsc70 (10 mM), Hdj1 (10 mM), Hsp70 (10 mM) and Apg-2
(10 mM) (each individual combination is an individual category of the x-axis) in the absence (blue bars) or presence of Hsp104 (2.5 mM, green bars; or
10 mM, black bars). Fiber integrity was then determined by sedimentation analysis (C) or by ThT fluorescence (D). Values represent means 6 SEM
(n=3).
doi:10.1371/journal.pone.0026319.g005
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Cytosol preparation
Rat liver cytosol (RLC) [78] and sHeLa interphase cytosol
[79,80] were prepared as described, except that protease inhibitors
(complete cocktail (Roche) and 5 mM pepstatin A (Sigma)) were
included in all buffers and at the final step cytosol was buffer
exchanged into either luciferase refolding buffer (LRB: 25 mM
HEPES-KOH pH 7.4, 150 mM KAOc, 10 mM MgAOc, 10 mM
DTT) plus ATP (5 mM) or GFP refolding buffer (GRB: 25 mM
HEPES-KOH, pH 7.4, 100 mM KCl, 20 mM MgCl2,5 m M
DTT, 0.1 mM EDTA, 10% (v/v) glycerol) plus ATP (5 mM).
Protein concentration, measured by Bio-Rad protein assay in
comparison to BSA standards, was typically 12–15 mg/ml. After
preparation, cytosol was immediately snap frozen and stored in
liquid N2.
Cytosol depletion
RLC and SHC were depleted of p97 using a GST-tagged p97-
binding fragment of Ufd1, UT6 (amino acids 215–327), as
described [60] and GST was used for the mock depletion. Hsc70,
Hsp70, Hdj1, Hdj2, Hsp105, and Apg-2 were immunodepleted
using an anti-Hsc70 rat monoclonal (#SPA-815; Enzo Life
Sciences), an anti-Hsp70 mouse monoclonal (#ADI-SPA-810;
Enzo Life Sciences), an anti-Hdj1 rabbit polyclonal (#SPA-400;
Enzo Life Sciences), an anti-Hdj-2 mouse monoclonal (#MS-225;
Lab Vision/Thermo), an anti-Hsp105 rabbit polyclonal antibody
(#ab24503; Abcam) and an anti-Apg-2 mouse monoclonal
antibody (#A-7; Santa Cruz) respectively. For mock depletions,
normal mouse, rat or rabbit IgG was employed. Antibodies were
covalently coupled to protein G-sepharose (GE) with DMP
(Pierce/Thermo) to achieve 2–10 mg antibody per ml resin.
100 ml of antibody-coupled beads were added to 800 ml RLC or
SHC, and incubated for 2 h with rotation at 4uC. Beads were then
recovered and the supernatant was added to fresh antibody-
coupled beads. This process was repeated four times. To
determine the extent of depletion, cytosol preparations (20 mg)
were fractionated by SDS-PAGE and the concentration of the
protein of interest was determined by quantitative immunoblot in
comparison to known quantities of pure protein. Typically, .93%
depletion of the target protein was achieved. From these studies,
the concentration of Hsc70, Hdj1 and Apg-2 in 10 mg/ml RLC
was estimated to be: 15 mM, 1.2 mM, and 4.2 mM respectively.
Similarly, the concentration of Hsc70, Hdj1 and Apg-2 in 10 mg/
ml SHC was estimated to be: 12 mM, 1 mM, and 3.8 mM
respectively. Thus, in add-back experiments (Figure 2), pure
Hsc70, Hdj1 and Apg-2 were added back to the appropriate
depleted cytosol at these concentrations.
Protein purification
Sse1, Ssa1 and Sis1 variants were generated by Quikchange
Lightning Site-Directed Mutagenesis (Agilent). Hsp104 [18], Ssa1
[18], Sis1 [18], Ydj1 [18], Sse1 [49], Apg-2 [49], Fes1 [68],
Snl1DN [69], Sup35 [19], GFP [57], and a-synuclein [81] were
purified as described. Hsp70, Hsc70, Hdj1 and Hdj2 were from
Enzo Life Sciences. The activity of Hsp70:Hsp40 pairs and
Hsp110 chaperones was confirmed by their ability to suppress the
aggregation of denatured luciferase as described [10]. The NEF
activity of Sse1, Fes1 and Snl1DN preparations was confirmed as
described [69]. Firefly luciferase and apyrase were from Sigma and
creatine kinase was from Roche. The purity of all proteins was
determined by SDS-PAGE and Coomassie staining to be .98%.
The Hsp104 concentration refers to the hexamer concentration.
Luciferase disaggregation and reactivation
Luciferase reactivation was performed as described [10]. Briefly,
to assemble aggregates, firefly luciferase (50 mM) in LRB plus 8M
urea was incubated at 30uC for 30 min. The sample was then
rapidly diluted 100-fold into LRB. Aliquots were snap frozen and
stored at 280uC until use. Aggregated luciferase (50 nM) was
incubated with the indicated components plus ATP (5 mM) and
an ATP regeneration system (1 mM creatine phosphate, 0.25 mM
creatine kinase) for 0–6 h at 25uC. Cytosol preparations were
added to a final concentration of 10 mg/ml. In disaggregation
reactions with pure components, Hsp104, Hsp110, Hsp70, Hsp40
or variants were added to a final concentration of 1 mM. In some
reactions, the p97 small-molecule inhibitor, DBeQ (Interbiosc-
reen), or the Hsp70/Hsc70 small molecule inhibitor, VER 155008
(Tocris), was added to final concentration of 100 mM. In other
reactions, ATP and the regeneration system were omitted, or
replaced with AMP-PNP (5 mM). Apyrase (2 U/ml) was substi-
tuted for the ATP regeneration system in other experiments. At
the end of the reaction, luciferase activity was assessed with a
luciferase assay system (Promega). Recovered luminescence was
monitored using a Tecan Safire
2 or Infinite M1000 plate reader.
Luminescence measurements were converted into reactivation
yield (% of the maximum recoverable luciferase activity) by
comparison to the luminescence of known quantities of soluble,
native luciferase.
GFP disaggregation and reactivation
GFP disaggregation was essentially as described [57]. Briefly, to
assemble aggregates, GFP (4.5 mM) in GRB was incubated for
15 min at 85uC. GFP aggregates (0.45 mM) were then incubated
with the indicated components plus ATP (5 mM) and an ATP
regeneration system (as above for luciferase reactivation) for 0–6 h
at 25uC. Disaggregation and refolding of GFP was monitored by
fluorescence at 510 nm upon excitation at 395 nm. Fluorescence
measurements were converted into reactivation yield (% of the
maximum recoverable GFP fluorescence) by comparison to the
fluorescence of known quantities of soluble, native GFP.
Sup35 prion disaggregation
Sup35 prion disaggregation was performed as described
[19,20]. Full-length Sup35 (10 mM) was assembled into prions
capable of converting [psi
-] yeast cells to [PSI
+] by incubation in
assembly buffer (AB; 40 mM HEPES-KOH pH 7.4, 150 mM
KCl, 20 mM MgCl2 and 1 mM DTT) plus 10% (v/v) glycerol and
GTP (1 mM) for 16 h with rotation (80rpm on a mini-rotator,
Glas-Col) at 25uC [19,20]. Sup35 prions (2 mM Sup35 monomer)
were then incubated in AB plus ATP (5 mM) and ATP-
regeneration system with the indicated combination of Hsp104
(0.5–2 mM), Sse1 (2 mMo r2 0mM), Ssa1 (2 mMo r2 0mM) and
Sis1 (2 mMo r2 0mM) for 6 h at 25uC. Prion disaggregation was
then assessed by determining the percentage of the total Sup35
that was soluble in 2% SDS (Sup35 prions resist dissolution by this
concentration of SDS) or by the fluorescence of the amyloid-
diagnostic dye Thioflavin-T (ThT) (excitation: 450 nm; emission:
482 nm) as described [19,20,74].
a-Syn fiber disaggregation
a-Syn fiber disaggregation was performed as described [17].
Thus, a-syn (80 mM) was assembled into amyloid in AB for 48 h
with agitation (1,400rpm in an Eppendorf Thermomixer) at 37uC.
a-syn fibers (0.5 mM monomer) were then incubated for 6 h at
37uC in AB plus ATP (5 mM) and ATP-regeneration system
without or with the indicated combination of Hsc70 (10 mM),
Protein Disaggregation by Hsp110, Hsp70 and Hsp40
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or presence of Hsp104 (2.5 mMo r1 0mM). Fiber integrity was
then determined by sedimentation analysis: reactions were
centrifuged at 436,000 g for 10 min at 25uC. Supernatant and
pellet fractions were then resolved by SDS-PAGE and processed
for immunoblot. The percentage of the total a-syn in the pellet was
determined by densitometry and comparison to know quantities of
a-syn [17]. Alternatively, a-syn fiber integrity was assessed by ThT
fluorescence [17].
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